Cargando…

MLC901 in hypoxic-ischemic brain injury patients: A double-blind, randomized placebo-controlled pilot study

Hypoxic-ischemic brain injury (HIBI) is a disabling consequence of cardiopulmonary resuscitation, which has no direct treatment except supportive care. Many studies have used pharmacological agents to reduce or stop this disability. MLC901 is a traditional Chinese medicine showing neuroprotective an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pakdaman, Hossein, Gharagozli, Koroush, Karamiani, Faezeh, Shamsi Goushki, Maryam, Moini, Saman, Sobhanian, Ali, Maghsoudlu, Faeze, Esfandani, Akram, Hosseini, Mohammad Hossein, Amini Harandi, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5300
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256404/ https://www.ncbi.nlm.nih.gov/pubmed/37335674 http://dx.doi.org/10.1097/MD.0000000000033914

Ejemplares similares

Efficacy and Safety of MLC601 in Patients with Mild to Moderate Alzheimer Disease: An Extension 4-Year Follow-Up Study
por: Pakdaman, Hossein, et al.
Publicado: (2018)

MLC601 in vascular dementia: an efficacy and safety pilot study
por: Pakdaman, Hossein, et al.
Publicado: (2017)

Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study
por: Pakdaman, Hossein, et al.
Publicado: (2017)

Epilepsy lifetime prevalence in Iran: a large population- based national survey
por: Pakdaman, Hossein, et al.
Publicado: (2021)

Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial
por: Pakdaman, Hossein, et al.
Publicado: (2015)

Frequency distribution of the first clinical symptoms in the Iranian population with multiple sclerosis
por: Gharagozli, Kurosh, et al.
Publicado: (2012)

Positive effects of the traditional Chinese medicine MLC901 in cognitive tasks
por: Lorivel, T., et al.
Publicado: (2015)

Role of MLC901 in increasing neurogenesis in rats with traumatic brain injury
por: Rosyidi, Rohadi Muhammad, et al.
Publicado: (2020)

Vitamin D and multiple sclerosis
por: Harandi, Asghar Amini, et al.
Publicado: (2014)

Is it time to revise the classification of geographical distribution of multiple sclerosis?
por: Sahraian, Mohammad Ali, et al.
Publicado: (2012)

The Traditional Chinese Medicine MLC901 inhibits inflammation processes after focal cerebral ischemia
por: Widmann, C., et al.
Publicado: (2018)

Topiramate for hypoxic ischemic encephalopathy: A systematic review protocol
por: Chen, Guoming, et al.
Publicado: (2020)

Influence of MLC901 Alone and with Moderate Exercise on Pain Response Concurrent Due to Stress of Male Mice
por: Nasehi, Maryam, et al.
Publicado: (2019)

The role of MLC901 in reducing VEGF as a vascular permeability marker in rats with spinal cord injury
por: Wahyudi, et al.
Publicado: (2022)

Neural injury of the Papez circuit following hypoxic–ischemic brain injury: A case report
por: Jang, Sung Ho, et al.
Publicado: (2016)

Brain metabolism in patients with freezing of gait after hypoxic-ischemic brain injury: A pilot study
por: Yoon, Seo Yeon, et al.
Publicado: (2017)

Persian version of frontal assessment battery: Correlations with formal measures of executive functioning and providing normative data for Persian population
por: Asaadi, Sina, et al.
Publicado: (2016)

Safety and Use of MLC601/MLC901 (NeuroAiD(TM)) in Primary Intracerebral Hemorrhage: A Cohort Study from the NeuroAiD Safe Treatment Registry
por: Kumar, Ramesh, et al.
Publicado: (2020)

Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences
por: Jafari Khaljiri, Helia, et al.
Publicado: (2021)

Acute and long-term cardioprotective effects of the Traditional Chinese Medicine MLC901 against myocardial ischemia-reperfusion injury in mice
por: Vincent, Anne, et al.
Publicado: (2017)

MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: a pilot randomized clinical trial
por: Theadom, A., et al.
Publicado: (2018)

Clinical features and outcomes of Myasthenia Gravis associated with COVID-19 vaccines: A systematic review and pooled analysis
por: Tayebi, Amir Hossein, et al.
Publicado: (2023)

The likelihood approach for potential role of “GABRG2 (C588T, C315T) gene polymorphisms” on the poor response to carbamazepine therapy in Pakhtun population of Pakistan
por: Ullah, Shakir, et al.
Publicado: (2022)

NEURoaid II (MLC901) in cognitively Impaired not demenTEd patientS (NEURITES): A pilot double blind, placebo‐controlled randomized trial
por: Chen, Christopher L. H., et al.
Publicado: (2021)

Systematic Review and Meta-Analysis of the Efficacy of MLC901 (NeuroAiD II(TM)) for Acute Ischemic Brain Injury in Animal Models
por: Ranuh, I. G. M. Aswin R., et al.
Publicado: (2021)

Myasthenia Gravis Development and Crisis Subsequent to Multiple Sclerosis
por: Gharagozli, Kurosh, et al.
Publicado: (2011)

Phase 1b dose-escalation, safety, and pharmacokinetic study of IC14, a monoclonal antibody against CD14, for the treatment of amyotrophic lateral sclerosis
por: Henderson, Robert D., et al.
Publicado: (2021)

Trigeminal Neuralgia as the First Clinical Manifestation of Anti-Hu Paraneoplastic Syndrome Induced by a Borderline Ovarian Mucinous Tumor
por: Kalanie, Hossein, et al.
Publicado: (2014)

Safety and Efficacy of MLC601 in Iranian Patients after Stroke: A Double-Blind, Placebo-Controlled Clinical Trial
por: Harandi, A. A., et al.
Publicado: (2011)

Can endotracheal intubation be the first step in management of nonconvulsive status epilepticus?: A case report
por: Warraich, Saad, et al.
Publicado: (2018)

Developing a novel prediction model in opioid overdose using machine learning; a pilot analytical study
por: Sakhaee, Ehsan, et al.
Publicado: (2022)

Electroencephalographic evidence of gray matter lesions among multiple sclerosis patients: A case-control study
por: Salim, Ahmed Abduljawad, et al.
Publicado: (2021)

An atypical presentation of primary central nervous system lymphoma: A case report
por: Yuen, Carlen A., et al.
Publicado: (2020)

Over-the-counter analgesic powder use in patients presenting with intracerebral hemorrhage: A case series
por: Raza, Syed Ali, et al.
Publicado: (2018)

Efficacy of tumour-treating fields therapy in recurrent glioblastoma: A narrative review of current evidence
por: Olatunji, Gbolahan, et al.
Publicado: (2023)

The effect of stem cell therapy and comprehensive physical therapy in motor and non-motor symptoms in patients with multiple sclerosis: A comparative study
por: Alghwiri, Alia A., et al.
Publicado: (2020)

Randomised, double-blind, placebo-controlled study investigating Safety and efficAcy of MLC901 in post-traUmatic bRAin Injury: the SAMURAI study protocol
por: Pilipenko, Pavel, et al.
Publicado: (2022)

New diagnostic criteria for multiple sclerosis in patients with clinically isolated syndromes: Some questions could be raised during clinical practice
por: Sahraian, Mohammad Ali, et al.
Publicado: (2012)

New Cerebral Microbleeds After Mechanical Thrombectomy for Large-Vessel Occlusion Strokes
por: Shi, Zhong-Song, et al.
Publicado: (2015)

Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge
por: Kalanie, Hossein, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_d4vpsqev4q9i37ug4hgdhglkoa